Cargando…

An analysis of polygenic risk scores for non-alcoholic fatty liver disease

Detalles Bibliográficos
Autor principal:	Jun, Dae Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273633/ https://www.ncbi.nlm.nih.gov/pubmed/34024056 http://dx.doi.org/10.3350/cmh.2021.0133

Ejemplares similares

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
por: Bianco, Cristiana, et al.
Publicado: (2021)

Polygenic risk scores and rheumatic diseases
por: Brown, Matthew A., et al.
Publicado: (2021)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Headaches and polygenic scores
por: Vilhjálmsson, Bjarni J., et al.
Publicado: (2019)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Generalisation of genomic findings and applications of polygenic risk scores
por: Corpas, Manuel, et al.
Publicado: (2023)

Optimal diagnosis and management of non-alcoholic fatty liver disease
Publicado: (2022)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

The association of healthy lifestyle score and risk of non-alcoholic fatty liver disease
por: Jahromi, Mitra Kazemi, et al.
Publicado: (2023)

Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
por: O'Brien, Alastair
Publicado: (2022)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
por: Yoon, Eileen Laurel, et al.
Publicado: (2023)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
por: Oh, Hyunwoo, et al.
Publicado: (2016)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
por: Shim, Ju Hyun
Publicado: (2020)

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
por: Di Costanzo, Alessia, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
por: Kwon, Ja-Young
Publicado: (2022)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Polygenic risk scores and their potential clinical use in psychiatry: are we there yet?
por: Fries, Gabriel R.
Publicado: (2020)

Polygenic risk scores and early manifestations of attention‐deficit/hyperactivity disorder
por: Larsson, Henrik, et al.
Publicado: (2022)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
por: Sinn, Dong Hyun, et al.
Publicado: (2014)

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores
por: Lee, Yong-ho, et al.
Publicado: (2014)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

What's in a disease like non‐alcoholic fatty liver disease—East versus West?
por: Dan, Yock Young
Publicado: (2022)

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease
por: Gallo, Paolo, et al.
Publicado: (2023)

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
por: Jansen, Peter L. M.
Publicado: (2021)

Quantitative imaging tests for non-alcoholic fatty liver disease: which, when and why
por: Dennis, Andrea
Publicado: (2023)

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
por: Kasper, Philipp, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0777b35hgmiibquqmja4tv1qra